Clearside Biomedical (FRA:CLM) NonCurrent Deferred Liabilities : €0.00 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Clearside Biomedical NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Clearside Biomedical's non-current deferred liabilities for the quarter that ended in Mar. 2025 was €0.00 Mil.

Clearside Biomedical NonCurrent Deferred Liabilities Historical Data

The historical data trend for Clearside Biomedical's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearside Biomedical NonCurrent Deferred Liabilities Chart

Clearside Biomedical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

Clearside Biomedical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Clearside Biomedical NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Clearside Biomedical's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearside Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearside Biomedical Inc (FRA:CLM) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

CLSD:USA

Address

900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005

Website

https://www.clearsidebio.com

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.